- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Fundacion Cancer FUCA
Total 2854 results
-
Fuda Cancer Hospital, GuangzhouCompleted
-
Fuda Cancer Hospital, GuangzhouCompleted
-
Fuda Cancer Hospital, GuangzhouCompleted
-
Fuda Cancer Hospital, GuangzhouCompleted
-
Fuda Cancer Hospital, GuangzhouCompleted
-
Fuda Cancer Hospital, GuangzhouJinan University GuangzhouCompleted
-
Fuda Cancer Hospital, GuangzhouJinan University GuangzhouCompleted
-
Fuda Cancer Hospital, GuangzhouJinan University GuangzhouCompleted
-
Fuda Cancer Hospital, GuangzhouJinan University GuangzhouCompleted
-
Fuda Cancer Hospital, GuangzhouUniversity of MichiganCompleted
-
Fuda Cancer Hospital, GuangzhouJinan University GuangzhouCompletedMetastasis From Malignant Tumor of Kidney (Disorder) | Reaction - Mixed VaccineChina
-
Fuda Cancer Hospital, GuangzhouJinan University GuangzhouCompleted
-
Fuda Cancer Hospital, GuangzhouJinan University GuangzhouCompleted
-
Fuda Cancer Hospital, GuangzhouUniversity of MichiganCompleted
-
Fuda Cancer Hospital, GuangzhouUniversity of MichiganCompleted
-
Fuda Cancer Hospital, GuangzhouJinan University GuangzhouCompletedPancreatic CancerChina
-
Fuda Cancer Hospital, GuangzhouJinan University GuangzhouCompleted
-
Fuda Cancer Hospital, GuangzhouUniversity of MichiganCompletedNeoplasms,ColorectalChina
-
Fuda Cancer Hospital, GuangzhouJinan University GuangzhouCompletedMetastatic Colorectal Cancer | Reaction - Mixed VaccineChina
-
Fuda Cancer Hospital, GuangzhouUniversity of MichiganCompletedNeoplasms,OvarianChina
-
Fuda Cancer Hospital, GuangzhouUniversity of MichiganCompleted
-
Fuda Cancer Hospital, GuangzhouUniversity of MichiganCompleted
-
Fuda Cancer Hospital, GuangzhouShenzhen Hank Bioengineering InstituteCompletedLiver Tumor | Evidence of Liver TransplantationChina
-
Fuda Cancer Hospital, GuangzhouShenzhen Hank Bioengineering InstituteCompletedTongue CancerChina
-
Fuda Cancer Hospital, GuangzhouShenzhen Hank Bioengineering InstituteCompletedMetastatic Esophageal CancerChina
-
Fuda Cancer Hospital, GuangzhouShenzhen Hank Bioengineering InstituteCompletedSecondary Malignant Neoplasm of LiverChina
-
Fuda Cancer Hospital, GuangzhouShenzhen Hank Bioengineering InstituteCompletedRecurrent Liver CarcinomaChina
-
Fuda Cancer Hospital, GuangzhouShenzhen Hank Bioengineering InstituteCompletedNon-small Cell Lung Cancer MetastaticChina
-
Fuda Cancer Hospital, GuangzhouShenzhen Hank Bioengineering InstituteCompletedRecurrent Pharyngeal CancerChina
-
Fuda Cancer Hospital, GuangzhouShenzhen Hank Bioengineering InstituteCompletedRecurrent Adult Soft Tissue SarcomaChina
-
Fuda Cancer Hospital, GuangzhouShengxin Biotechnology Institute, BeijingCompleted
-
Fuda Cancer Hospital, GuangzhouShengxin Biotechnology Institute, BeijingCompleted
-
Fuda Cancer Hospital, GuangzhouShengxin Biotechnology Institute, BeijingCompleted
-
Fuda Cancer Hospital, GuangzhouShenzhen Hank Bioengineering InstituteCompletedMalignant Solid TumourChina
-
Fuda Cancer Hospital, GuangzhouShenzhen Hank Bioengineering InstituteCompletedMalignant Solid TumourChina
-
Fuda Cancer Hospital, GuangzhouShenzhen Hank Bioengineering InstituteCompleted
-
Fuda Cancer Hospital, GuangzhouShenzhen Hank Bioengineering InstituteCompletedRecurrent Ovarian CancerChina
-
Fuda Cancer Hospital, GuangzhouShenzhen Hank Bioengineering InstituteCompleted
-
Fuda Cancer Hospital, GuangzhouShenzhen Hank Bioengineering InstituteCompletedPancreatic CancerChina
-
Fuda Cancer Hospital, GuangzhouShenzhen Hank Bioengineering InstituteCompletedMetastatic Renal Cell CancerChina
-
Fuda Cancer Hospital, GuangzhouShengxin Biotechnology Institute, BeijingCompleted
-
Fuda Cancer Hospital, GuangzhouShenzhen Hank Bioengineering InstituteCompletedRecurrent Tongue CancerChina
-
Fuda Cancer Hospital, GuangzhouShenzhen Hank Bioengineering InstituteCompletedRecurrent Breast CancerChina
-
Fuda Cancer Hospital, GuangzhouShenzhen Hank Bioengineering InstituteCompletedPancreatic CancerChina
-
Fuda Cancer Hospital, GuangzhouShenzhen Hank Bioengineering InstituteCompletedRecurrent Non-small Cell Lung CancerChina
-
Fuda Cancer Hospital, GuangzhouShenzhen Hank Bioengineering InstituteCompletedRecurrent Laryngeal CancerChina
-
Fuda Cancer Hospital, GuangzhouShenzhen Hank Bioengineering InstituteCompletedMalignant Solid TumourChina
-
Fuda Cancer Hospital, GuangzhouShenzhen Hank Bioengineering InstituteCompletedNon-small Cell Lung Cancer MetastaticChina
-
Fuda Cancer Hospital, GuangzhouShenzhen Hank Bioengineering InstituteCompletedRecurrent Cervical CancerChina
-
Fuda Cancer Hospital, GuangzhouShenzhen Hank Bioengineering InstituteCompletedBreast Cancer RecurrentChina